Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion type Assertion NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_head.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion evidence source_evidence_literature NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion SIO_000772 23033490 NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion wasDerivedFrom befree-20150227 NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion wasGeneratedBy ECO_0000203 NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.